News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MELLETT PAUL J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 100 shares
@ $43.96, valued at
$4.4k
Sold 10,340 shares
@ $44.43, valued at
$459.4k
Exercised 10,440 options to buy
@ $14, valued at
$146.2k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 2,812 options to buy
@ $14.18, valued at
$39.9k
|
|
| 12/19/2022 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 4,148 options to buy
@ $14.18, valued at
$58.8k
|
|
| 12/05/2022 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,055 shares
@ $44.33, valued at
$46.8k
|
|
| 11/28/2022 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 21,000 shares
@ $0
Granted 45,000 options to buy
@ $45, valued at
$2M
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 615 shares
@ $0
Granted 2,419 shares
@ $0
Paid exercise price by delivering 958 shares
@ $62.49, valued at
$59.9k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 6,800 shares
@ $0
Granted 28,400 options to buy
@ $75.33, valued at
$2.1M
|
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 770 shares
@ $42.52, valued at
$32.7k
Exercised 2,625 restricted stock units
@ $0 |
|
| 11/20/2020 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,600 shares
@ $0
Granted 30,800 options to buy
@ $43.57, valued at
$1.3M
|
|
| 11/12/2020 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 3,480 options to buy
@ $2.5429, valued at
$8.8k
|
|
| 05/07/2020 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 1,740 options to buy
@ $1.2068, valued at
$2.1k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,165 shares
@ $63.88, valued at
$74.4k
Sold 9,279 shares
@ $60.8192, valued at
$564.3k
Sold 721 shares
@ $61.6619, valued at
$44.5k
Exercised 2,625 restricted stock units
@ $0 |
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2018 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 19,000 options to buy
@ $81.2, valued at
$1.5M
|
|
| 06/20/2018 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 6,960 options to buy
@ $1.9826, valued at
$13.8k
|
|
| 06/12/2018 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 300 shares
@ $117.5233, valued at
$35.3k
Sold 2,600 shares
@ $119.3479, valued at
$310.3k
Sold 6,336 shares
@ $120.3686, valued at
$762.7k
Sold 5,153 shares
@ $121.4163, valued at
$625.7k
Sold 611 shares
@ $122.1733, valued at
$74.6k
|
|
| 03/20/2018 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $85.0455, valued at
$85k
Sold 3,900 shares
@ $86.0031, valued at
$335.4k
Sold 3,900 shares
@ $87.2528, valued at
$340.3k
Sold 200 shares
@ $87.935, valued at
$17.6k
|
|
| 02/13/2018 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 2,300 shares
@ $0
Granted 5,546 shares
@ $0
Paid exercise price by delivering 2,367 shares
@ $76.845, valued at
$181.9k
|
|
| 11/21/2017 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 22,500 options to buy
@ $48.52, valued at
$1.1M
|
|
| 04/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/29/2016 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 3,478 options to buy
@ $14, valued at
$48.7k
|
|
| 07/22/2016 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 3,484 options to buy
@ $14, valued at
$48.8k
|
|
| 02/29/2016 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 6,689 options to buy
@ $1.293, valued at
$8.6k
|
|
|
|
|